Sellas Life Sciences Group Inc (SLS)

Jun 15, 2026

SLS Stock Tests $5 Again: Retail Targets ‘No’ Vote On 20M Share Dilution Push Before AML Trial Results - Stocktwits

Jun 15, 2026

Jun 14, 2026

SLS Stock Hits Over 3-Year High As AML Drug Trial Nears Final Readout — Wall Street Sees 30% More Upside - Stocktwits

Jun 14, 2026

Jun 14, 2026

SLS Stock Jumps Premarket: CEO Says GPS AML Data Has ‘Very Good Chance’ To Beat Earlier Survival Outcomes - Stocktwits

Jun 14, 2026

Jun 14, 2026

SLS Stock Falls Premarket: CEO Touts GPS Leukemia Strategy, But Investors Stay Cautious As AML Trial Nears Readout - Stocktwits

Jun 14, 2026

Jun 14, 2026

SLS Stock Jumps Overnight: ‘Potent’ AML Drug Data Ahead Of Cancer Summit Fuels Fresh Momentum - Stocktwits

Jun 14, 2026

Jun 14, 2026

SLS Stock Gains Momentum: NVDA, MSFT Investor Loads Up Ahead Of AML Trial Milestone Trigger - Stocktwits

Jun 14, 2026

Jun 14, 2026

SLS Stock Rises Overnight: Traders Rally Behind Jim Cramer's 'Two Thumbs Up' Call Ahead Of Key AML Readout - Stocktwits

Jun 14, 2026

Jun 14, 2026

SLS Stock Sparks Retail Buzz Ahead of AACR Presentation On Experimental Cancer Therapy - Stocktwits

Jun 14, 2026

Jun 13, 2026

SLS CEO Angelos Stergiou Highlights Extended Capital Runway To Pursue Key Milestones, Growth Opportunities – A Look At The Important Numbers - Stocktwits

Jun 13, 2026

Jun 13, 2026

SLS Stock Pops Big After Hours On Imminent Leukemia Trial Data Readout Optimism - Stocktwits

Jun 13, 2026

Jun 13, 2026

SLS stock jumps overnight: CEO doubles down on ‘steadfast’ confidence in AML drug and pushes for 20M share plan approval - MSN

Jun 13, 2026

Jun 13, 2026

SLS stock slides premarket: Traders brace for key arbitration ruling in GPS China payment dispute - MSN

Jun 13, 2026

Jun 12, 2026

SLS Stock Rallies Ahead Of AML Trial Readout — ‘Pharma Bro’ Martin Shkreli Says He’s Still ‘Very Bearish,’ Predicts Drug Will Fail - Stocktwits

Jun 12, 2026

Jun 11, 2026

Why did ARM, SLS, EBAY stocks surge to 52-week highs? - MSN

Jun 11, 2026

Jun 11, 2026

SELLAS Life Sciences Group (SLS) price target increased by 15.38% to 10.20 - MSN

Jun 11, 2026

Jun 11, 2026

SLS Stock Extends Rally Overnight: CEO Says ‘Bullish’ Leukemia Data Could Drive NCCN Recognition For GPS - Stocktwits

Jun 11, 2026

Jun 11, 2026

SLS Stock’s Red-Hot Streak Draws Rising Short Bets — Retail Traders Are Now Betting On A Big Pharma Buyout - Stocktwits

Jun 11, 2026

Jun 11, 2026

SLS Stock Slides Premarket: Traders Brace For Key Arbitration Ruling In GPS China Payment Dispute - Stocktwits

Jun 11, 2026

Jun 11, 2026

Sellas Life Sciences Draws Significant Retail Buzz As Traders Eye REGAL Phase 3 Catalyst – SLS Stock Soars 15% - Stocktwits

Jun 11, 2026

Jun 11, 2026

Sellas Life Sciences draws significant retail buzz as traders eye REGAL phase 3 catalyst – SLS stock soars 15% - MSN

Jun 11, 2026

Jun 10, 2026

SLS stock extends rally overnight: CEO says 'bullish' leukemia data could drive NCCN recognition for GPS - MSN

Jun 10, 2026

Jun 08, 2026

SLS Stock Takes A Breather After Big Run: Traders Eye AML Summit Featuring Advisor For Clues On Trial Readout - Stocktwits

Jun 08, 2026